McKesson Corporation: stock overview

MCKNYSEHealthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Price

$1,102.81

November 13, 2026Market cap $133B

What Ploutos Investor adds for McKesson

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

McKesson had revenue of $419B over the last 12 months and net income of $4.7B, a net margin of 1.1%. Revenue grew by 11.1% a year on average over the last 5 years. At $1,102.81 the shares trade at a P/E of 28.2, against a median of 24.0 over the last 5 fiscal years. It has net debt of $2.7B. It pays a dividend yielding 0.31%.

From its SEC filings (latest fiscal year to March 31, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$133B
120M shares
P/E
28.2
Today28.2
Median24.0
Revenue, 12 months
$419B
+11.1% a year over 5 years
Net margin
1.1%
FY2025: 1.2%, above 71% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+14.3% a year over 2 years

  • FY2026Mar 31, 202610-K
    Revenue$403B
  • FY2025Mar 31, 202510-K
    Revenue$359B
  • FY2024Mar 31, 202410-K
    Revenue$309B

Fiscal years in figures

MCK's revenue, profit, cash flow and dividend with each year-end price, from FY2010 to FY2023, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $84.2B
$133B
Enterprise value 
$135B
P/E 3-year median: 24.0
28.2
EV / EBIT 
20.2
EV / Revenue 
0.3
P/B 
–
FCF yield 3-year median: 5.6%
5.4%
Earnings yield 3-year median: 4.2%
3.6%

Profitability

Gross margin 
3.7%
Operating margin 
1.6%
Net margin 3-year median: 1.0%
1.1%
ROIC 
104.0%
ROIC, 5-year average 
86.4%
ROE 
–

Growth

Revenue, yearly change 
+12.4%
EPS, yearly change 
+49.2%
FCF, yearly change 
+3.1%
Revenue, average a year 
+11.1%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$6.5B
Total debt 
$11.2B
Of which operating leases 
$2.0B
Net debt 
$2.7B
Net debt / EBITDA 
0.4x
Interest cover 
21.9x
Current ratio 
0.90

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 3-year median: 0.4%
0.31%
Buybacks 
3.58%
Total returned 
3.89%
Shares, yearly change 
-3.9%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 51).

Gross margin

3.6%

Above 26% of the 36 companies in its industry, and 4% of all.

Operating margin

1.5%

Above 57% of the 38 companies in its industry, and 39% of all.

Net margin

1.2%

Above 71% of the 39 companies in its industry, and 39% of all.

ROA

5.7%

Above 80% of the 38 companies in its industry, and 75% of all.

Revenue growth

12.4%

Above 88% of the 39 companies in its industry, and 68% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

Contracts with the US government

What the federal government committed in contracts to the company and its subsidiaries, by federal fiscal year (October to September).

$11.9B Fiscal year 2025

In federal fiscal year 2025 (October 2024 to September 2025) the US government committed $11.9B in contracts to the company and its subsidiaries. The year before it was $8.3B. That is about 3.0% of its revenue in the fiscal year to March 31, 2026 ($403B), though an amount committed is not revenue.

Fiscal year 2022Oct 2021 to Sep 2022

$12.3B

Fiscal year 2023Oct 2022 to Sep 2023

$9.7B

Fiscal year 2024Oct 2023 to Sep 2024

$8.3B

Fiscal year 2025Oct 2024 to Sep 2025

$11.9B

Fiscal year 2026Oct 2025 to Sep 2026

$15.0B

From USAspending.gov, the federal government's public spending records, as of November 1, 2026. An amount committed is not revenue of the same year: a contract running several years counts when it is signed, and the company is paid as it does the work. The company is matched through the parent company the government records it under, which adds up its subsidiaries. A subsidiary recorded under another parent can be missing.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
MCKESSON CORP
Exchange
NYSE
Industry (SIC)
5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fiscal year ends
March 31
Latest annual report
March 31, 2026
Reporting currency
USD
Shares
120M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do McKesson's filings show?

These are McKesson's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MCK

Didn't find what you were looking for?

Ask us
What is MCK's market cap?

McKesson Corporation's market cap is $133B, at a price of $1,102.81 on November 13, 2026 and 120M shares.

What is MCK's P/E?

MCK's P/E is 28.2, on earnings per share of $38.83 over the last 12 months. The median over the last 5 fiscal years was 24.0.

How much revenue does MCK have?

McKesson had revenue of $419B over the last 12 months. Over the last 5 years it changed by +11.1% a year on average.

Does MCK pay a dividend?

Yes. McKesson paid $3.40 per share over the last 12 months, a yield of 0.31% at today's price. All the figures are in the Dividend section.

Where do the figures come from?

From McKesson Corporation's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.